Performant Healthcare Inc - Common Stock - $0.0001 par value (PHLT) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock - $0.0001 par value
Symbol
PHLT
Shares outstanding
80,439,690
Price per share
$7.67
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
6
Total reported value
$46
Share change
-78,778,168
Value change
-$608,958,053
Number of holders
1
Price from insider filings
$7.67
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Performant Healthcare Inc - Common Stock - $0.0001 par value (PHLT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
First Light Asset Management, LLC 16% $53,117,291 12,923,915 Mathew P. Arens 30 Jun 2025
GLAZER CAPITAL, LLC 8.4% +43% $52,231,100 +$16,704,515 6,756,934 +47% Glazer Capital, LLC 30 Sep 2025
VANGUARD GROUP INC 4.9% -1.2% $30,734,503 +$425,761 3,976,003 +1.4% The Vanguard Group 30 Sep 2025

As of 31 Dec 2025, 1 institutional investors reported holding 6 shares of Performant Healthcare Inc - Common Stock - $0.0001 par value (PHLT). This represents 0% of the company’s total 80,439,690 outstanding shares.

Institutional Holders of Performant Healthcare Inc - Common Stock - $0.0001 par value (PHLT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 6 $46 -$608,958,053 $7.67 1
2025 Q3 78,826,042 $609,328,119 +$123,788,201 $7.73 118
2025 Q2 68,135,578 $272,546,030 +$9,576,367 $4.00 84
2025 Q1 66,391,280 $196,521,963 +$862,347 $2.96 79
2024 Q4 66,086,004 $199,583,051 +$1,881,715 $3.02 75
2024 Q3 58,891,734 $220,253,383 +$3,236,368 $3.74 76
2024 Q2 57,729,700 $167,416,363 +$898,456 $2.90 68
2024 Q1 57,367,911 $168,598,709 +$1,191,127 $2.94 73
2023 Q4 56,862,123 $177,545,533 +$8,021,780 $3.12 73
2023 Q3 54,619,896 $123,442,190 +$2,512,035 $2.26 70
2023 Q2 53,445,642 $144,302,176 +$1,174,542 $2.70 70
2023 Q1 51,730,311 $175,878,839 +$11,544,440 $3.40 64
2022 Q4 48,258,458 $174,215,043 +$12,211,816 $3.61 51
2022 Q3 44,632,732 $82,571,000 -$368,756 $1.85 37
2022 Q2 45,204,609 $118,919,000 +$5,177,253 $2.63 43
2022 Q1 43,207,970 $134,379,000 +$4,992,794 $3.11 45
2021 Q4 41,733,357 $100,581,000 -$9,633,959 $2.41 43
2021 Q3 42,356,731 $167,667,000 +$58,452,742 $3.96 53
2021 Q2 27,590,480 $103,464,000 +$20,611,909 $3.75 34
2021 Q1 22,210,066 $47,752,000 +$3,620,667 $2.15 24
2020 Q4 20,543,050 $18,098,000 -$8,245,748 $0.88 19
2020 Q3 25,756,542 $24,174,000 -$205,746 $0.94 17
2020 Q2 25,985,872 $16,984,000 -$325,003 $0.66 17
2020 Q1 26,486,063 $23,784,000 -$745,427 $0.90 19
2019 Q4 26,717,491 $27,249,000 +$244,618 $1.02 20
2019 Q3 30,277,600 $33,305,000 -$22,377 $1.10 26
2019 Q2 30,297,631 $31,815,000 -$2,577,291 $1.05 23
2019 Q1 30,324,897 $62,770,000 -$658,537 $2.07 26
2018 Q4 30,612,343 $68,879,000 +$910,840 $2.25 26
2018 Q3 30,210,193 $63,329,000 -$166,030 $2.05 27
2018 Q2 30,256,712 $65,050,000 -$1,876,561 $2.15 29
2018 Q1 30,163,017 $90,491,000 +$544,317 $3.00 36
2017 Q4 30,016,598 $49,526,000 -$10,495 $1.65 30
2017 Q3 27,761,174 $50,521,000 -$32,554 $1.82 31
2017 Q2 27,771,598 $58,039,000 +$581,746 $2.09 35
2017 Q1 27,494,822 $80,563,000 +$215,899 $2.93 37
2016 Q4 27,617,532 $64,900,000 +$440,399 $2.35 44
2016 Q3 26,755,472 $78,929,000 -$1,942,466 $2.95 38
2016 Q2 28,280,490 $45,805,706 -$1,237,825 $1.62 39
2016 Q1 29,012,129 $49,317,415 -$402,589 $1.70 47
2015 Q4 29,143,158 $52,137,000 -$4,192,302 $1.79 44
2015 Q3 30,880,849 $74,711,000 -$2,287,708 $2.42 48
2015 Q2 31,488,571 $101,991,000 -$6,601,877 $3.24 60
2015 Q1 33,049,349 $112,298,738 -$6,993,885 $3.40 78
2014 Q4 32,919,891 $218,696,804 +$2,374,732 $6.65 87
2014 Q3 31,964,859 $258,515,690 +$10,263,678 $8.08 86
2014 Q2 29,394,110 $296,812,980 +$10,103,170 $10.10 87
2014 Q1 28,430,174 $257,220,135 +$6,759,266 $9.05 78